Stocksigma LogoStocksigma Logo

Zydus Lifesciences Completes Acquisition of Sterling Biotech API Business

Zydus Lifesciences Limited has formally completed the acquisition of the active pharmaceutical ingredient (API) business of Sterling Biotech Limited

Zydus Lifesciences Completes Acquisition of Sterling Biotech API Business

Zydus Lifesciences Ltd 路 Others (Uncategorized) 路 02 Nov 2026, 6:16 pm

Zydus Lifesciences Completes Acquisition of Sterling Biotech API Business Zydus Lifesciences Limited has formally completed the acquisition of the active pharmaceutical ingredient (API) business of Sterling Biotech Limited. The transaction concluded following the fulfillment of all conditions precedent and closing date adjustments outlined in the Business Transfer Agreement originally executed between the parties on 17th Sep'24.

Original exchange filing (PDF)

More announcements from Zydus Lifesciences Ltd

All Zydus Lifesciences Ltd announcements